03Jul
Abbott Laboratories has pleaded guilty and agreed to pay $1.5 billion over allegations that it promoted the anti-seizure drug Depakote for uses that were not approved by the Food and Drug Administration.
Tags: Abbott Laboratories, anti-seizure drug, Depakote, FDA
